Advertisement

Topics

Multiple Myeloma: Update Bulletin 2 [Report Updated: 01122017] Prices from USD $1095

00:41 EDT 17 Apr 2018 | BioPortfolio Reports




This edition presents key opinion leader KOL views on recent developments in the multiple myeloma MM market. Topics covered include; Amgen's announcement of topline results of the Phase III A.R.R.O.W. trial for carfilzomib Kyprolis administered onceweekly at the 70 mg/m2 dose with dexamethasone in rrMM patients; FDA's partial clinical hold suspending patient recruitment in three studies of BMS' nivolumab Opdivobased combinations in rrMM: CheckMate602, CheckMate039 and CA204142; and BioLineRx's regulatory filings tolaunch the Phase III GENESIS trial for BL8040 for the mobilization of hematopoietic stem cells for autologous transplantation in MM patients


Business Questions:


How do experts view Amgen's topline results for the Phase III A.R.R.O.W. trial?

How do KOLs view the results for the higher dose carfilzomib Kyprolis and will it impact prescribing of bortezomib Velcade and ixazomib Ninlaro?

What do experts say about potential increase in cardiovascular complications with the higher dose carfilzomib?

How do experts view the clinical hold on CheckMate602, CheckMate039 and CA204142?

Is there a future for PD1/PDL1based combinations in multiple myeloma?

What do experts expect from BioLineRx's Phase III GENESIS trial for BL8040?

How do KOLs perceive BL8040 potential for the mobilization of hematopoietic stem cells for autologous transplantation in patients?

Could BL8040 replace Sanofi's plerixafor Mozobil and become the new standard of care?

Original Article: Multiple Myeloma: Update Bulletin 2 [Report Updated: 01122017] Prices from USD $1095

NEXT ARTICLE

More From BioPortfolio on "Multiple Myeloma: Update Bulletin 2 [Report Updated: 01122017] Prices from USD $1095"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...